NEO-CONCEPT INTL GROUP HLD-A (NCI) Fundamental Analysis & Valuation

NASDAQ:NCI • KYG6421C1208

Current stock price

8.01 USD
-3.38 (-29.68%)
At close:
7 USD
-1.01 (-12.61%)
After Hours:

This NCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NCI Profitability Analysis

1.1 Basic Checks

  • In the past year NCI was profitable.
NCI Yearly Net Income VS EBIT VS OCF VS FCFNCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

  • The Return On Assets of NCI (7.33%) is better than 82.22% of its industry peers.
  • The Return On Equity of NCI (17.36%) is better than 77.78% of its industry peers.
  • The Return On Invested Capital of NCI (11.38%) is better than 77.78% of its industry peers.
Industry RankSector Rank
ROA 7.33%
ROE 17.36%
ROIC 11.38%
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI Yearly ROA, ROE, ROICNCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • NCI's Profit Margin of 3.41% is in line compared to the rest of the industry. NCI outperforms 57.78% of its industry peers.
  • In the last couple of years the Profit Margin of NCI has grown nicely.
  • NCI's Operating Margin of 4.67% is in line compared to the rest of the industry. NCI outperforms 48.89% of its industry peers.
  • NCI's Operating Margin has improved in the last couple of years.
  • NCI has a Gross Margin of 25.43%. This is amonst the worse of the industry: NCI underperforms 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of NCI has grown nicely.
Industry RankSector Rank
OM 4.67%
PM (TTM) 3.41%
GM 25.43%
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
NCI Yearly Profit, Operating, Gross MarginsNCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NCI Health Analysis

2.1 Basic Checks

  • NCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NCI has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, NCI has an improved debt to assets ratio.
NCI Yearly Shares OutstandingNCI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M
NCI Yearly Total Debt VS Total AssetsNCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 14.98 indicates that NCI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NCI (14.98) is better than 100.00% of its industry peers.
  • There is no outstanding debt for NCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.98
ROIC/WACC0.99
WACC11.53%
NCI Yearly LT Debt VS Equity VS FCFNCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

2.3 Liquidity

  • A Current Ratio of 1.85 indicates that NCI should not have too much problems paying its short term obligations.
  • NCI's Current ratio of 1.85 is in line compared to the rest of the industry. NCI outperforms 46.67% of its industry peers.
  • A Quick Ratio of 1.70 indicates that NCI should not have too much problems paying its short term obligations.
  • NCI's Quick ratio of 1.70 is amongst the best of the industry. NCI outperforms 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.7
NCI Yearly Current Assets VS Current LiabilitesNCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NCI Growth Analysis

3.1 Past

  • NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.16%, which is quite impressive.
  • The Earnings Per Share has been growing by 15.35% on average over the past years. This is quite good.
  • NCI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.75%.
  • The Revenue has been decreasing by -0.68% on average over the past years.
EPS 1Y (TTM)75.16%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%34.02%
Revenue 1Y (TTM)16.75%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%-24%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCI Yearly Revenue VS EstimatesNCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100M 200M 300M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NCI Valuation Analysis

4.1 Price/Earnings Ratio

  • NCI is valuated rather expensively with a Price/Earnings ratio of 24.27.
  • NCI's Price/Earnings ratio is a bit more expensive when compared to the industry. NCI is more expensive than 64.44% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, NCI is valued at the same level.
Industry RankSector Rank
PE 24.27
Fwd PE N/A
NCI Price Earnings VS Forward Price EarningsNCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCI indicates a rather expensive valuation: NCI more expensive than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 106.71
NCI Per share dataNCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NCI Dividend Analysis

5.1 Amount

  • NCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NCI Fundamentals: All Metrics, Ratios and Statistics

NEO-CONCEPT INTL GROUP HLD-A

NASDAQ:NCI (3/13/2026, 8:00:02 PM)

After market: 7 -1.01 (-12.61%)

8.01

-3.38 (-29.68%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.06%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap151.47M
Revenue(TTM)295.90M
Net Income(TTM)10.10M
Analysts60
Price TargetN/A
Short Float %98.66%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.27
Fwd PE N/A
P/S 4.01
P/FCF N/A
P/OCF N/A
P/B 20.38
P/tB 25.84
EV/EBITDA 106.71
EPS(TTM)0.33
EY4.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2
BVpS0.39
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.71
Profitability
Industry RankSector Rank
ROA 7.33%
ROE 17.36%
ROCE 13.79%
ROIC 11.38%
ROICexc 11.59%
ROICexgc 13.25%
OM 4.67%
PM (TTM) 3.41%
GM 25.43%
FCFM N/A
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.04%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.7
Altman-Z 14.98
F-ScoreN/A
WACC11.53%
ROIC/WACC0.99
Cap/Depr(3y)604.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.96%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.16%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%34.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.75%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%-24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.08%
EBIT growth 3Y37.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.87%
OCF growth 3Y-65.32%
OCF growth 5YN/A

NEO-CONCEPT INTL GROUP HLD-A / NCI Fundamental Analysis FAQ

What is the fundamental rating for NCI stock?

ChartMill assigns a fundamental rating of 4 / 10 to NCI.


What is the valuation status for NCI stock?

ChartMill assigns a valuation rating of 0 / 10 to NEO-CONCEPT INTL GROUP HLD-A (NCI). This can be considered as Overvalued.


Can you provide the profitability details for NEO-CONCEPT INTL GROUP HLD-A?

NEO-CONCEPT INTL GROUP HLD-A (NCI) has a profitability rating of 4 / 10.